Is Actinium Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 4 Wall Street analysts covering (NYSEMKT: ATNM) stock is to Strong Buy ATNM stock.
Out of 4 analysts, 3 (75%) are recommending ATNM as a Strong Buy, 1 (25%) are recommending ATNM as a Buy, 0 (0%) are recommending ATNM as a Hold, 0 (0%) are recommending ATNM as a Sell, and 0 (0%) are recommending ATNM as a Strong Sell.
According to 4 Wall Street analysts that have issued a 1 year ATNM price target, the average ATNM price target is $29.25, with the highest ATNM stock price forecast at $50.00 and the lowest ATNM stock price forecast at $16.00.
On average, Wall Street analysts predict that Actinium Pharmaceuticals's share price could reach $29.25 by Apr 1, 2025. The average Actinium Pharmaceuticals stock price prediction forecasts a potential upside of 345.88% from the current ATNM share price of $6.56.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.